Newswise — Dr. Joan Schiller is chief of hematology/oncology and deputy director of the Harold C. Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center.
The focus of Dr. Schiller's research throughout her career in oncology has been drug development for small-cell and non-small-cell lung cancer. In addition to her work in cytotoxic therapies, she is active in the investigation of molecularly targeted agents for the treatment of lung cancer.
A recognized expert in lung cancer, Dr. Schiller is chairwoman of the Thoracic Oncology Committee of the Eastern Cooperative Oncology Group, one of the largest clinical cancer research organizations in the United States.
Dr. Schiller also is president of the National Lung Cancer Partnership, a nonprofit educational and advocacy group that focuses on women.
Dr. David Euhus is a professor of surgical oncology at UT Southwestern Medical Center in Dallas and director of the Cancer Genetics Clinic at the Harold C. Simmons Comprehensive Cancer Center.
Dr. Euhus' research interests are in the areas of cancer genetics, breast cancer risk assessment and breast cancer prevention.
He created the popular CancerGene software program which is used for genetic risk assessment in cancer centers across the nation. His laboratory, which is funded by the National Cancer Institute and the American Cancer Society, investigates molecular markers of breast cancer risk in benign breast cells from high-risk women.
Dr. Robert Timmerman, vice-chairman of radiation oncology at the University of Texas Southwestern Medical Center in Dallas, is an internationally recognized authority on stereotactic radiosurgery.
Dr. Timmerman was one of the first researchers who translated the stereotactic treatments commonly done in the central nervous system to sites within the body. He is a pioneer in applying stereotactic radiosurgery to tumor sites, including the lungs and the liver.
To speak with experts, please contact the source.